Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions, Inc. Announces 27% Revenue Growth for its Second Quarter and Provides Company Update
EDEN PRAIRIE, Minn. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today its second quarter results for the period ended June 30 , 2018.  Highlights include: Revenue for second quarter ended June 30, 2018 increased 27 percent compared to the same period in 2017 and
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Second Quarter Financial Results on August 7, 2018
EDEN PRAIRIE, Minn. , July 31, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announces today that its second quarter 2018 financial results will be released on Tuesday, August 7, 2018 . The company will host a conference call and webcast at 9:00 AM EDT that morning, during which
View HTML
Toggle Summary Department of Veterans Affairs Awards a $6.5 million Blanket Purchase Agreement to CHF Solutions to Supply Aquadex FlexFlow System for Outpatient Services in Tampa, Fla.
EDEN PRAIRIE, Minn. , July 25, 2018 (GLOBE NEWSWIRE) -- As previously disclosed on its website, FedBizOps.gov, the United States Department of Veterans Affairs has awarded CHF Solutions, Inc. (Nasdaq:CHFS) a blanket purchase agreement from the United States Department of Veterans Affairs to supply
View HTML
Toggle Summary CHF Solutions, Inc. Enters the German Market
EDEN PRAIRIE, Minn. , July 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH , a business solutions resource based in Germany . HSC-Medical will serve as a fulfillment house and
View HTML
Toggle Summary CHF Solutions, Inc. Announces Closing of Common Stock Offering
EDEN PRAIRIE, Minn. , July 03, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of its previously-announced underwritten public offering of 2,547,169 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of $5.4 million ,
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Common Stock Offering
EDEN PRAIRIE, Minn. , June 29, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of 2,214,930 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of approximately $4.7 million prior to
View HTML
Toggle Summary CHF Solutions, Inc. Hires Additional Field Sales Representatives and Expands Territories
EDEN PRAIRIE, Minn. , June 20, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS), today announces it has expanded its commercial sales team with the addition of three seasoned field sales representatives, growing its sales outreach from 10 to 13 territories.
View HTML
Toggle Summary CHF Solutions to Exhibit at the 14th Annual American Association of Heart Failure Nurses Meeting
EDEN PRAIRIE, Minn. , June 06, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:CHFS), today announces that it will be exhibiting at the 14 th Annual American Association of Heart Failure Nurses Meeting from June 28-30, 2018 in Chicago . The company will be featuring the Aquadex FlexFlow System and
View HTML
Toggle Summary CHF Solutions to Present at the LD Micro 8th Annual Invitational on June 4, 2018
EDEN PRAIRIE, Minn. , May 30, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS), today announces that Claudia Drayton , chief financial officer of CHF Solutions , will be a featured presenter at the LD Micro Invitational Conference on Monday June 4, 2018 at 2:30 PM Pacific Time .
View HTML
Toggle Summary New Data Presented at ISPOR Shows Ultrafiltration Therapy Demonstrates a Cost Savings of $3,975 Per Patient at 90 Days
EDEN PRAIRIE, Minn. , May 24, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq:CHFS) announced today that a cost analysis 1 from the hospital perspective showed substantial cost savings at 90 days when using an ultrafiltration system versus diuretic therapy.  This research was presented in a
View HTML